Doctor profile · Federal record
Dr. Molly Braddock, PA-C
Physician Assistant · Swansea, IL
- NPI 1881134765
- Accepts Medicare
- 10 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4948 Benchmark Centre Dr
Swansea, IL 622262027
(618) 628-2588
fax (618) 628-1363
Credentials & registration
- NPI registered
- February 2017 — 9 yrs on file
- Profile last updated
- January 3, 2020
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Illinois #085.006105
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881134765. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,797
Distinct HCPCS
10
Medicare allowed
$70,583
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 715 | 145 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 227 | 189 | $76 | |
17000 |
Destruction of precancer skin growth, 1 growth | 218 | 188 | $45 | |
17110 |
Destruction of skin growth, 1-14 growths | 133 | 119 | $92 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 90 | 84 | $47 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 89 | 15 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 87 | 84 | $77 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 76 | 66 | $106 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 45 | 45 | $61 | |
11103 |
Biopsy of related skin growth, each additional growth | 40 | 22 | $41 |
In context: peer comparison
Among 5 peers in Swansea Physician Assistant, average services per provider: 178. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$3,234
Transactions
163
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 34 | $626.95 | |
| Sun Pharmaceutical Industries INC. | 16 | $330.10 | |
| E.R. Squibb & Sons, L.L.C. | 21 | $302.66 | |
| Leo Pharma INC. | 12 | $291.48 | |
| Novartis Pharmaceuticals Corporation | 12 | $258.76 | |
| Dermavant Sciences, INC. | 15 | $255.81 | |
| Janssen Biotech, INC. | 9 | $172.11 | |
| Amgen INC. | 9 | $170.07 | |
| Ucb, INC. | 11 | $167.81 | |
| Lilly USA, LLC | 8 | $146.35 | |
| Incyte Corporation | 5 | $142.73 | |
| Pfizer INC. | 6 | $116.45 | |
| Regeneron Healthcare Solutions, INC. | 1 | $57.82 | |
| Genzyme Corporation | 2 | $39.62 | |
| Verrica Pharmaceuticals INC. | 2 | $35.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
246
Patients
145
Total drug cost
$83,275
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 44 | 35 | $2,390 |
| Triamcinolone Acetonide | Generic | 42 | 38 | $478 |
| Doxycycline Hyclate | Generic | 40 | 21 | $892 |
| Hydrocortisone | Generic | 30 | 23 | $191 |
| Ketoconazole | Generic | 22 | 17 | $562 |
| Spironolactone | Generic | 18 | 0 | $326 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 14 | 0 | $998 |
| Hydroxyzine Hcl | Generic | 13 | 0 | $61 |
| Taltz Autoinjector (Ixekizumab) | Brand | 12 | 0 | $77,296 |
| Mupirocin | Generic | 11 | 11 | $81 |
Frequently asked questions
What is Dr. Molly Braddock's medical specialty?
Dr. Molly Braddock practices Physician Assistant in Swansea, IL.
Where does Dr. Molly Braddock practice?
Dr. Molly Braddock practices at 4948 Benchmark Centre Dr, Swansea, IL 622262027. Office phone: 6186282588.
What is Dr. Molly Braddock's NPI?
Dr. Molly Braddock's National Provider Identifier (NPI) is 1881134765, issued by NPPES.
Does Dr. Molly Braddock accept Medicare assignment?
Yes. Dr. Molly Braddock accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Molly Braddock commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.